Find effective medications for 'Myasthenia Gravis treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

Last year, the FDA placed a partial clinical hold on tolebrutinib phase 3 trials in MS and myasthenia gravis after cases of drug-induced liver injury were observed, with recruitment of new studies ...

These are really exciting times, I think, for patients with myasthenia gravis. In 2017, a drug was approved and that was the first FDA drug approved in over 40 years in the treatment of myasthenia ...

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

The frequency of adverse events associated with drug-induced Q-T interval prolongation is unknown. As the population ages, a greater number of patients receive additional drug therapies for a ...

Myasthenia gravis. Systemic sclerosis ... Monitor weight, growth, fluid and electrolyte balance. IV: drug-induced liver injury; discontinue if toxic hepatitis occurs. Intrasynovial: avoid ...

Myasthenia gravis. Systemic sclerosis ... Monitor weight, growth, fluid and electrolyte balance. IV: drug-induced liver injury; discontinue if toxic hepatitis occurs. Intrasynovial: avoid ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...